Healthtech Startups

Nerai is a biotechnology company developing personalized CRISPR-based genome editors through its MORPHEME platform, which combines automated directed evolution, high-throughput functional screening, and machine learning. It focuses on one-time genetic therapies for rare inherited diseases, with initial programs targeting the liver and retina.

1 investor

Neru Health provides an AI platform, Nora, that automates patient onboarding, therapy adherence monitoring, resupply optimization, and EHR/data management for durable medical equipment (DME) providers. It integrates with DME software, scheduling systems, and phone trees to reduce operating costs, improve Medicare/PAP compliance, and route exceptions to clinical and resupply teams.

1 investor

Nerveli develops digital support for people managing chronic pain, providing science-backed daily guidance between medical appointments through understanding pain mechanisms and nervous system responses. The platform is designed for chronic pain patients and works alongside healthcare providers.

1 investor

NerView Surgical develops the NerveSense System, a non-invasive optical imaging device that provides real-time nerve visualization during open surgical procedures to help surgeons avoid intraoperative nerve injuries. It targets surgical teams, including head and neck and reconstructive specialties, in the medical device industry.

1 investor

NervMyo Therapeutics develops a long-acting injectable delivery system combining a FDA-approved biologic (IGF-1) to improve nerve regrowth and prevent muscle wasting following peripheral nerve injury. The company targets nerve injury patients requiring regenerative therapeutics.

1 investor

Nest provides software tools to veterinary hospitals for managing pet wellness plans and preventative care programs. The platform helps clinics streamline compliance, increase wellness plan revenue, and improve pet health outcomes.

1 investor

Nested Bean designs gently weighted baby sleepwear intended to mimic a parent's touch and help infants sleep. Its product line includes swaddles, sleep sacks, footies and onesies sold direct to parents.

1 investor

Netmeds.com is an Indian online pharmacy that sells prescription medicines, OTC products, wellness items, and health supplements with home delivery across India, including smaller cities and rural areas. It also offers generic alternatives, drug information, and refill reminders for consumers managing chronic and everyday health needs.

1 investor

Neuemoon is a health platform built to support young girls and women in understanding menstrual health and accessing information about conditions like endometriosis and fibroids. The company aims to help women recognize abnormal symptoms and connect with appropriate medical care earlier than traditional pathways.

1 investor

Neukio is a biopharmaceutical company developing iPSC-derived cell technology platforms and next-generation off-the-shelf, mass-producible immune cell products (such as NK cells) to treat solid tumors and autoimmune diseases. It focuses on innovation in both product and process development to lower cell therapy production costs and expand indication coverage.

1 investor

Getneuma builds the MouthPad, a custom-fit intraoral touchpad that lets users control cursors, clicks, scrolling, and dragging on computers, phones, and tablets through tongue, head, and breath gestures over Bluetooth. An MIT Media Lab spin-off focused on hands-free human augmentation and accessibility, it also offers VOX, a wearable microphone for quiet-speech dictation, and sells only within the United States.

1 investor

Neumentum is a specialty pharmaceutical company developing non-opioid analgesic and neurology products for pain management. It has four novel non-opioid products in development aimed at treating pain while avoiding the abuse, misuse, and respiratory side effects associated with opioids.

1 investor

Neupulse develops a wearable device that delivers drug-free, non-invasive neurostimulation to support everyday wellbeing and relaxation, based on neuroscience research. It sells a consumer wellness device with an accompanying app, and is also developing a clinical version currently going through regulatory approval, with an initial launch planned in Great Britain.

1 investor

NeurAbilities Healthcare provides diagnostic and therapeutic services for patients with neurological and developmental conditions, combining precision medicine, behavioral sciences, and therapeutic treatments. It serves patients seeking neurological and behavioral healthcare.

1 investor

Neuralert develops a patented algorithm and wearable technology aimed at early stroke detection. The company operates in the medical device and digital health space, with ties to University of Pennsylvania neurology research.

1 investor

NeuralTeks develops AI-powered tools for laboratory analysis, specifically targeting microbiology and microbial identification in pharmaceutical, biotechnology, and analytical settings. The platform aims to accelerate analysis speed, improve accuracy, and reduce costs for laboratory operations.

1 investor

Neuraly is a clinical-stage biotechnology company developing disease-modifying treatments for neurodegenerative disorders, focusing on inhibiting pathological glial activation to prevent neuronal cell death. Its lead candidate NLY01 has been evaluated in Phase 2 trials for early Parkinson's disease.

1 investor

NeuraVue provides AI-powered monitoring systems for senior care facilities and independent living settings, detecting falls, wandering, and distress to alert caregivers and family members in real time. The platform serves independent living communities, assisted living facilities, skilled nursing homes, and aging-in-place scenarios, with specialized capabilities for dementia care.

1 investor

NeurAxis develops neuromodulation therapies targeting the gut-brain axis for patients with disorders of gut-brain interaction, such as functional abdominal pain associated with irritable bowel syndrome and functional dyspepsia. Its lead device delivers drug-free, non-surgical nerve stimulation for pediatric and adult patients.

1 investor

Neurescue develops a medical device that treats cardiac arrest patients by inserting a balloon-occlusion device through the femoral artery to increase blood flow to the heart and brain during chest compressions. The device targets patients ineligible for defibrillation and uses automated pressure-limited inflation to improve resuscitation outcomes.

1 investor

Neurobiome LLC is developing the M.E. Gut-Brain chip, a microfluidic screening tool that uses dynamic flow and high-throughput testing to identify microbiome-mediated neuroactive compounds and probiotic strains. It targets early-stage screening for probiotic and pharmaceutical development aimed at mental and neurological health conditions.

1 investor

Neuro-Bio is an Oxfordshire-based biotech company developing a biomarker and a diagnostic for Alzheimer's disease based on a novel hypothesis of the neurodegenerative process, originating from research at Oxford University. It also pursues neuroprotection approaches, with its first patent covering chemical composition of matter.

1 investor

Neurobit analyzes physiological signals recorded during sleep to identify patterns associated with cardiovascular disease, stroke, and dementia risk. Its AI models are trained on more than a trillion data points of multi-channel physiological data and are designed to work across different devices, signal types, and patient populations. The company's aim is a health analytics platform that treats sleep as a general-purpose biomarker for clinicians and researchers.

1 investor

Neurochase provides consultancy to biotech and pharmaceutical companies on directly delivering therapies to the central nervous system, drawing on experience with catheter infusions and convection-enhanced delivery. It supports preclinical study protocols, toxicology, surgical workflow and training, and is developing its own CED drug-delivery devices.

1 investor